NASDAQ: EXAS 47.54
Change: -5.42 -10.23% Minimum 20 min delay
3:08 PM ET on Jan 17, 2018
Volume: 12,523,609

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

36th Annual J.P. Morgan Healthcare Conference Presentation January 7, 2018
Download (PDF 1.24 MB)